Immunoassay Systems

Global Immunoassay Systems Market to Reach US$29.9 Billion by 2030

The global market for Immunoassay Systems estimated at US$24.2 Billion in the year 2024, is expected to reach US$29.9 Billion by 2030, growing at a CAGR of 3.6% over the analysis period 2024-2030. Reagents & Kits, one of the segments analyzed in the report, is expected to record a 3.5% CAGR and reach US$19.4 Billion by the end of the analysis period. Growth in the Analyzers / Instruments segment is estimated at 2.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$6.5 Billion While China is Forecast to Grow at 6.2% CAGR

The Immunoassay Systems market in the U.S. is estimated at US$6.5 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$6.2 Billion by the year 2030 trailing a CAGR of 6.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.7% and 4.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.5% CAGR.

Global Immunoassay Systems Market - Key Trends and Drivers Summarized

Immunoassay systems are indispensable tools in clinical diagnostics and biomedical research, employing biochemical tests to measure specific macromolecules or small molecules in complex mixtures. They leverage antibody-based reactions for sensitive and specific detection and quantification of antigens or antibodies in various body fluids, playing a vital role in qualitative and quantitative analysis of biological samples. The market for these systems is poised for continuous growth, driven by technological advancements, the increasing burden of diseases like diabetes and cancer, and the expanding global healthcare infrastructure, especially in managing age-related conditions among the elderly.

Advancements in technology have led to the development of sophisticated immunoassay systems with enhanced sensitivity, faster results, and greater throughput. Technologies such as chemiluminescence immunoassay (CLIA) and enzyme-linked immunosorbent assay (ELISA) are in demand for their improved accuracy and reliability. Moreover, automation and integration with laboratory information systems (LIS) are trends shaping the future of immunoassay systems, reducing human error and enhancing diagnostic workflows. Portable systems for point-of-care testing are also gaining traction, particularly in managing chronic diseases and emergency medicine, where rapid decision-making is crucial.

Additionally, customization, flexibility, and a focus on precision medicine are driving the demand for immunoassay systems tailored to specific laboratory needs. Multiplexed immunoassays, allowing simultaneous measurement of multiple analytes, are gaining popularity for their comprehensive analysis of biological samples. . Immunoassay systems are vital for identifying biomarkers and specific disease states, thus supporting personalized treatment plans. Laboratories are increasingly looking for immunoassay systems that can be customized to their specific needs. Systems that offer flexibility in terms of scalable throughput, open reagent systems, and a broad menu of tests are particularly appealing. Moreover, sustainability and eco-friendliness are becoming key considerations in system design, with manufacturers focusing on reducing energy consumption and waste production, aligning with global sustainability goals.

SCOPE OF STUDY:

The report analyzes the Immunoassay Systems market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Product (Reagents & Kits, Analyzers / Instruments, Software & Services); Technology (Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay, Other Technologies); End-Use (Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies, Other End-Uses)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 29 Featured) -

• Abbott Laboratories
• Beckman Coulter Inc.
• bioMérieux SA
• Bio-Rad Laboratories Inc.
• DiaSorin S.p.A
• Ortho-Clinical Diagnostics Inc.
• Quidel Corporation
• Roche Diagnostics
• Siemens Healthineers
• Sysmex Corporation
• Tosoh Bioscience Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.